nodes	percent_of_prediction	percent_of_DWPC	metapath
Tubocurarine—HTR3A—enteric nervous system—Parkinson's disease	0.0761	0.226	CbGeAlD
Tubocurarine—HTR3A—myenteric nerve plexus—Parkinson's disease	0.0577	0.172	CbGeAlD
Tubocurarine—CHRNA1—tongue—Parkinson's disease	0.0247	0.0736	CbGeAlD
Tubocurarine—HTR3A—nerve—Parkinson's disease	0.015	0.0447	CbGeAlD
Tubocurarine—CHRND—cardiovascular system—Parkinson's disease	0.0106	0.0316	CbGeAlD
Tubocurarine—CHRNA2—forebrain—Parkinson's disease	0.00871	0.0259	CbGeAlD
Tubocurarine—HTR3A—brainstem—Parkinson's disease	0.00645	0.0192	CbGeAlD
Tubocurarine—HTR3A—forebrain—Parkinson's disease	0.00622	0.0185	CbGeAlD
Tubocurarine—CHRNA1—head—Parkinson's disease	0.00601	0.0179	CbGeAlD
Tubocurarine—CHRNB1—medulla oblongata—Parkinson's disease	0.00585	0.0174	CbGeAlD
Tubocurarine—CHRNB1—midbrain—Parkinson's disease	0.00535	0.0159	CbGeAlD
Tubocurarine—CHRNB1—spinal cord—Parkinson's disease	0.00522	0.0155	CbGeAlD
Tubocurarine—CHRM2—forebrain—Parkinson's disease	0.00519	0.0154	CbGeAlD
Tubocurarine—SLC22A1—forebrain—Parkinson's disease	0.0051	0.0152	CbGeAlD
Tubocurarine—ACHE—medulla oblongata—Parkinson's disease	0.00508	0.0151	CbGeAlD
Tubocurarine—CHRNA2—head—Parkinson's disease	0.00499	0.0148	CbGeAlD
Tubocurarine—CHRNA2—nervous system—Parkinson's disease	0.00473	0.0141	CbGeAlD
Tubocurarine—CHRNB1—head—Parkinson's disease	0.00464	0.0138	CbGeAlD
Tubocurarine—ACHE—midbrain—Parkinson's disease	0.00464	0.0138	CbGeAlD
Tubocurarine—CHRNA2—central nervous system—Parkinson's disease	0.00455	0.0135	CbGeAlD
Tubocurarine—ACHE—spinal cord—Parkinson's disease	0.00453	0.0135	CbGeAlD
Tubocurarine—CHRNA2—cerebellum—Parkinson's disease	0.00445	0.0132	CbGeAlD
Tubocurarine—CHRM2—cardiovascular system—Parkinson's disease	0.00439	0.0131	CbGeAlD
Tubocurarine—CHRNA1—brain—Parkinson's disease	0.00435	0.013	CbGeAlD
Tubocurarine—CHRNB1—cerebellum—Parkinson's disease	0.00414	0.0123	CbGeAlD
Tubocurarine—CHRNA2—brain—Parkinson's disease	0.00361	0.0107	CbGeAlD
Tubocurarine—ACHE—cerebellum—Parkinson's disease	0.00359	0.0107	CbGeAlD
Tubocurarine—HTR3A—head—Parkinson's disease	0.00356	0.0106	CbGeAlD
Tubocurarine—HTR3A—nervous system—Parkinson's disease	0.00338	0.01	CbGeAlD
Tubocurarine—CHRNB1—brain—Parkinson's disease	0.00336	0.01	CbGeAlD
Tubocurarine—HTR3A—central nervous system—Parkinson's disease	0.00325	0.00968	CbGeAlD
Tubocurarine—CHRM2—head—Parkinson's disease	0.00297	0.00885	CbGeAlD
Tubocurarine—SLC22A1—head—Parkinson's disease	0.00292	0.00869	CbGeAlD
Tubocurarine—ACHE—brain—Parkinson's disease	0.00291	0.00867	CbGeAlD
Tubocurarine—CHRM2—nervous system—Parkinson's disease	0.00282	0.00839	CbGeAlD
Tubocurarine—SLC22A1—nervous system—Parkinson's disease	0.00277	0.00824	CbGeAlD
Tubocurarine—CHRM2—central nervous system—Parkinson's disease	0.00271	0.00807	CbGeAlD
Tubocurarine—SLC22A1—central nervous system—Parkinson's disease	0.00267	0.00793	CbGeAlD
Tubocurarine—HTR3A—brain—Parkinson's disease	0.00258	0.00768	CbGeAlD
Tubocurarine—CHRM2—brain—Parkinson's disease	0.00215	0.00641	CbGeAlD
Tubocurarine—SLC22A1—brain—Parkinson's disease	0.00212	0.0063	CbGeAlD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000432	0.000651	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—CHRNA4—Parkinson's disease	0.000429	0.000647	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—RPL6—Parkinson's disease	0.000426	0.000642	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000424	0.000639	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—GRM4—Parkinson's disease	0.000412	0.00062	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000408	0.000614	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.000404	0.000609	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.000404	0.000608	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—CHRNA4—Parkinson's disease	0.0004	0.000603	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000395	0.000595	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—HSPA8—Parkinson's disease	0.000394	0.000593	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000393	0.000593	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000392	0.00059	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—PENK—Parkinson's disease	0.00039	0.000588	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000388	0.000584	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000385	0.00058	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—COMT—Parkinson's disease	0.00038	0.000572	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—DRD3—Parkinson's disease	0.000378	0.000569	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—MAOA—Parkinson's disease	0.000377	0.000568	CbGpPWpGaD
Tubocurarine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000376	0.000567	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000375	0.000565	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00037	0.000558	CbGpPWpGaD
Tubocurarine—ACHE—ATF-2 transcription factor network—IL6—Parkinson's disease	0.00037	0.000557	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—DCTN1—Parkinson's disease	0.000369	0.000557	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—DLG4—Parkinson's disease	0.000369	0.000556	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000369	0.000556	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000368	0.000554	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—HSPA8—Parkinson's disease	0.000367	0.000553	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000365	0.00055	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—MCCC1—Parkinson's disease	0.000362	0.000546	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ND3—Parkinson's disease	0.000362	0.000546	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000362	0.000546	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—GRIN2B—Parkinson's disease	0.000361	0.000544	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—PDYN—Parkinson's disease	0.000357	0.000537	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—SLC6A3—Parkinson's disease	0.000356	0.000536	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000354	0.000534	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000351	0.000529	CbGpPWpGaD
Tubocurarine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000351	0.000528	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000349	0.000526	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—DLG4—Parkinson's disease	0.000344	0.000518	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000342	0.000515	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—DRD2—Parkinson's disease	0.000342	0.000515	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—TALDO1—Parkinson's disease	0.000341	0.000513	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—OMD—Parkinson's disease	0.000341	0.000513	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—GRIN2B—Parkinson's disease	0.000336	0.000507	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000332	0.000501	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—GRM5—Parkinson's disease	0.000332	0.0005	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—SLC6A3—Parkinson's disease	0.000332	0.000499	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—NDUFB11—Parkinson's disease	0.000323	0.000487	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—RPL23A—Parkinson's disease	0.000323	0.000486	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—RPL14—Parkinson's disease	0.000323	0.000486	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000321	0.000484	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000317	0.000478	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000317	0.000478	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000316	0.000477	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000313	0.000471	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—GPR37—Parkinson's disease	0.000311	0.000468	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—DGKQ—Parkinson's disease	0.000311	0.000468	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00031	0.000468	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GCH1—Parkinson's disease	0.000308	0.000464	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—COMT—Parkinson's disease	0.000302	0.000456	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—RPS8—Parkinson's disease	0.000301	0.000454	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000301	0.000453	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—MAOA—Parkinson's disease	0.0003	0.000452	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000292	0.000439	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ND3—Parkinson's disease	0.000289	0.000435	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—MCCC1—Parkinson's disease	0.000289	0.000435	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000284	0.000428	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000282	0.000425	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—COMT—Parkinson's disease	0.000282	0.000425	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—MAOA—Parkinson's disease	0.00028	0.000422	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000278	0.000419	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GBA—Parkinson's disease	0.000275	0.000414	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—FBP1—Parkinson's disease	0.000275	0.000414	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—DBH—Parkinson's disease	0.000275	0.000414	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000272	0.00041	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000272	0.00041	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000272	0.000409	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—TALDO1—Parkinson's disease	0.000272	0.000409	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—OMD—Parkinson's disease	0.000272	0.000409	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—MCCC1—Parkinson's disease	0.000269	0.000406	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ND3—Parkinson's disease	0.000269	0.000406	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000268	0.000404	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—GRK5—Parkinson's disease	0.000259	0.000391	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—NDUFB11—Parkinson's disease	0.000257	0.000388	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—OMD—Parkinson's disease	0.000253	0.000381	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—TALDO1—Parkinson's disease	0.000253	0.000381	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00025	0.000377	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000246	0.000371	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GCH1—Parkinson's disease	0.000246	0.00037	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—HTR1A—Parkinson's disease	0.000245	0.000369	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—TAC1—Parkinson's disease	0.000241	0.000363	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—NDUFB11—Parkinson's disease	0.00024	0.000361	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—DRD1—Parkinson's disease	0.000236	0.000356	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—GRK5—Parkinson's disease	0.000235	0.000355	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—GRM4—Parkinson's disease	0.000233	0.00035	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—DRD3—Parkinson's disease	0.000229	0.000345	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GCH1—Parkinson's disease	0.000229	0.000345	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000226	0.000341	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000222	0.000335	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—VPS35—Parkinson's disease	0.000221	0.000334	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PENK—Parkinson's disease	0.00022	0.000332	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—DBH—Parkinson's disease	0.000219	0.00033	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—FBP1—Parkinson's disease	0.000219	0.00033	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GBA—Parkinson's disease	0.000219	0.00033	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000218	0.000328	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—GRM4—Parkinson's disease	0.000211	0.000318	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—DRD2—Parkinson's disease	0.000207	0.000312	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—HTR7—Parkinson's disease	0.000207	0.000312	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—FBP1—Parkinson's disease	0.000204	0.000307	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—DBH—Parkinson's disease	0.000204	0.000307	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GBA—Parkinson's disease	0.000204	0.000307	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—DDC—Parkinson's disease	0.000202	0.000304	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PDYN—Parkinson's disease	0.000202	0.000304	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PENK—Parkinson's disease	0.0002	0.000302	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000197	0.000297	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000197	0.000296	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000191	0.000288	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSTA4—Parkinson's disease	0.00019	0.000287	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00019	0.000287	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000188	0.000283	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000187	0.000282	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000184	0.000277	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—DGKQ—Parkinson's disease	0.000184	0.000276	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GPR37—Parkinson's disease	0.000184	0.000276	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PDYN—Parkinson's disease	0.000183	0.000276	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—IGF2—Parkinson's disease	0.00018	0.000271	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000179	0.00027	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000178	0.000269	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PLA2G6—Parkinson's disease	0.000171	0.000258	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000171	0.000258	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—GRM5—Parkinson's disease	0.00017	0.000256	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—MAOB—Parkinson's disease	0.00017	0.000256	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000168	0.000253	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—EDN1—Parkinson's disease	0.000166	0.00025	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000162	0.000243	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—DDC—Parkinson's disease	0.000161	0.000242	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00016	0.00024	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000159	0.00024	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000153	0.000231	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTA4—Parkinson's disease	0.000152	0.000229	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—DDC—Parkinson's disease	0.00015	0.000226	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000149	0.000224	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—RIT2—Parkinson's disease	0.000147	0.000221	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000145	0.000218	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000145	0.000218	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000143	0.000215	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000143	0.000215	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTA4—Parkinson's disease	0.000141	0.000213	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	0.000139	0.00021	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000138	0.000208	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PLA2G6—Parkinson's disease	0.000137	0.000206	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000136	0.000205	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—MAOB—Parkinson's disease	0.000135	0.000204	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000134	0.000201	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	0.000129	0.000195	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PLA2G6—Parkinson's disease	0.000127	0.000192	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP2D6—Parkinson's disease	0.000126	0.00019	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—MAOB—Parkinson's disease	0.000126	0.00019	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000126	0.000189	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	0.000125	0.000188	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CTGF—Parkinson's disease	0.000124	0.000187	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	0.000124	0.000186	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	0.000121	0.000183	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000121	0.000182	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—INS—Parkinson's disease	0.000119	0.00018	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PENK—Parkinson's disease	0.000118	0.000178	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MAG—Parkinson's disease	0.000118	0.000178	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	0.000117	0.000177	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	0.000117	0.000176	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	0.000117	0.000176	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP2E1—Parkinson's disease	0.000115	0.000174	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000115	0.000174	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—NQO1—Parkinson's disease	0.000114	0.000172	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—TH—Parkinson's disease	0.000112	0.000169	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00011	0.000165	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	0.000108	0.000163	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYCS—Parkinson's disease	0.000108	0.000163	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	0.000106	0.00016	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	0.000106	0.00016	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	0.000102	0.000153	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	0.000101	0.000151	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP2D6—Parkinson's disease	0.000101	0.000151	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CTGF—Parkinson's disease	9.86e-05	0.000149	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—COMT—Parkinson's disease	9.56e-05	0.000144	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSTP1—Parkinson's disease	9.51e-05	0.000143	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—MAOA—Parkinson's disease	9.49e-05	0.000143	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—HMOX1—Parkinson's disease	9.38e-05	0.000141	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP2D6—Parkinson's disease	9.37e-05	0.000141	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	9.37e-05	0.000141	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CTGF—Parkinson's disease	9.19e-05	0.000139	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP2E1—Parkinson's disease	9.19e-05	0.000138	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—NQO1—Parkinson's disease	9.09e-05	0.000137	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ABCB1—Parkinson's disease	9.01e-05	0.000136	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—TH—Parkinson's disease	8.96e-05	0.000135	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	8.82e-05	0.000133	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSTM1—Parkinson's disease	8.74e-05	0.000132	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYCS—Parkinson's disease	8.6e-05	0.00013	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP2E1—Parkinson's disease	8.57e-05	0.000129	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	8.55e-05	0.000129	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	8.51e-05	0.000128	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—NQO1—Parkinson's disease	8.47e-05	0.000128	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GPX1—Parkinson's disease	8.37e-05	0.000126	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—TH—Parkinson's disease	8.35e-05	0.000126	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	8.19e-05	0.000123	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYCS—Parkinson's disease	8.02e-05	0.000121	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—INSR—Parkinson's disease	7.89e-05	0.000119	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—MTHFR—Parkinson's disease	7.73e-05	0.000116	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—COMT—Parkinson's disease	7.62e-05	0.000115	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTP1—Parkinson's disease	7.58e-05	0.000114	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—MAOA—Parkinson's disease	7.56e-05	0.000114	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—HMOX1—Parkinson's disease	7.48e-05	0.000113	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FGB—Parkinson's disease	7.46e-05	0.000112	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	7.44e-05	0.000112	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	7.42e-05	0.000112	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	7.31e-05	0.00011	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—APOE—Parkinson's disease	7.19e-05	0.000108	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ABCB1—Parkinson's disease	7.18e-05	0.000108	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	7.17e-05	0.000108	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—COMT—Parkinson's disease	7.1e-05	0.000107	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTP1—Parkinson's disease	7.07e-05	0.000106	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—MAOA—Parkinson's disease	7.05e-05	0.000106	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—HMOX1—Parkinson's disease	6.97e-05	0.000105	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTM1—Parkinson's disease	6.97e-05	0.000105	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	6.94e-05	0.000105	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ABCB1—Parkinson's disease	6.69e-05	0.000101	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GPX1—Parkinson's disease	6.67e-05	0.0001	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTM1—Parkinson's disease	6.49e-05	9.78e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	6.48e-05	9.76e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	6.28e-05	9.45e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	6.28e-05	9.45e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GPX1—Parkinson's disease	6.22e-05	9.37e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—MTHFR—Parkinson's disease	6.16e-05	9.27e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—INS—Parkinson's disease	6.15e-05	9.26e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—MTHFR—Parkinson's disease	5.74e-05	8.64e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—APOE—Parkinson's disease	5.73e-05	8.63e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—APOE—Parkinson's disease	5.34e-05	8.05e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	5.26e-05	7.92e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	5.08e-05	7.66e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	5.02e-05	7.57e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—INS—Parkinson's disease	4.9e-05	7.38e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	4.62e-05	6.96e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—INS—Parkinson's disease	4.56e-05	6.87e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	4.4e-05	6.62e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	4.09e-05	6.16e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—INS—Parkinson's disease	3.49e-05	5.26e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	2.6e-05	3.92e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	2.58e-05	3.89e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	2.39e-05	3.6e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	1.53e-05	2.3e-05	CbGpPWpGaD
